Article

Ultrasonography Helps Confirm Diagnosis of Early Arthritis

The presence of isolated synovial thickening in B-mode ultrasonography (US) or isolated bone erosion in US is not sufficient to confirm the diagnosis of early inflammatory arthritis. However, the presence of more than 1 case of joint synovitis or bone erosion is a strong argument for the diagnosis.

The presence of isolated synovial thickening in B-mode ultrasonography (US) or isolated bone erosion in US is not sufficient to confirm the diagnosis of early inflammatory arthritis. However, the presence of more than 1 case of joint synovitis or bone erosion is a strong argument for the diagnosis.

Millot and colleagues studied 127 healthy patients matched with the ESPOIR cohort of patients with early arthritis. US was used to assess the second and fifth metacarpophalangeal (MCP) joints and fifth metatarsophalangeal (MTP) joint of both hands and feet to detect bone erosion. The second, third, fourth, and fifth MCP joint and the fifth MTP joint were evaluated for synovial thickening in B-mode US and flow signal in power Doppler US.

Bone erosion and grade 2-3 synovial thickening in B-mode were seen in 11% and 9% of healthy patients, respectively. Receiver-operation characteristic curves revealed good discrimination and allowed a cutoff at 1 grade 2-3 synovial thickening in B-mode. To confirm the diagnosis of early arthritis with higher specificity, cutoff set at 2 joints with grade 2-3 synovial thickening in B-mode or 2 cases of bone
erosion gave optimal results.

The authors noted that there is no study of the diagnostic value of US in rheumatoid arthritis.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.